Literature DB >> 16467152

N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties.

Garry Milman1, Yehoshua Maor, Saleh Abu-Lafi, Michal Horowitz, Ruth Gallily, Sandor Batkai, Fong-Ming Mo, Laszlo Offertaler, Pal Pacher, George Kunos, Raphael Mechoulam.   

Abstract

The endocannabinoid N-arachidonoyl ethanolamine (anandamide), found both in the CNS and in the periphery, plays a role in numerous physiological systems. One might expect that the chemically related N-arachidonoyl-L-serine (ARA-S) could also be formed alongside anandamide. We have now isolated ARA-S from bovine brain and elucidated its structure by comparison with synthetic ARA-S. Contrary to anandamide, ARA-S binds very weakly to cannabinoid CB1 and CB2 or vanilloid TRPV1 (transient receptor potential vanilloid 1) receptors. However, it produces endothelium-dependent vasodilation of rat isolated mesenteric arteries and abdominal aorta and stimulates phosphorylation of p44/42 mitogen-activated protein (MAP) kinase and protein kinase B/Akt in cultured endothelial cells. ARA-S also suppresses LPS-induced formation of TNF-alpha in a murine macrophage cell line and in wild-type mice, as well as in mice deficient in CB1 or CB2 receptors. Many of these effects parallel those reported for abnormal cannabidiol (Abn-CBD), a synthetic agonist of a putative novel cannabinoid-type receptor. Hence, ARA-S may represent an endogenous agonist for this receptor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16467152      PMCID: PMC1413724          DOI: 10.1073/pnas.0510676103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

Review 1.  Endocannabinoids: a new class of vasoactive substances.

Authors:  M D Randall; D A Kendall
Journal:  Trends Pharmacol Sci       Date:  1998-02       Impact factor: 14.819

2.  Mesenteric vasodilation mediated by endothelial anandamide receptors.

Authors:  J A Wagner; K Varga; Z Járai; G Kunos
Journal:  Hypertension       Date:  1999-01       Impact factor: 10.190

3.  Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current.

Authors:  D Gebremedhin; A R Lange; W B Campbell; C J Hillard; D R Harder
Journal:  Am J Physiol       Date:  1999-06

4.  Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.

Authors:  P M Zygmunt; J Petersson; D A Andersson; H Chuang; M Sørgård; V Di Marzo; D Julius; E D Högestätt
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

5.  N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor.

Authors:  P F Pratt; C J Hillard; W S Edgemond; W B Campbell
Journal:  Am J Physiol       Date:  1998-01

6.  The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication.

Authors:  A T Chaytor; P E Martin; W H Evans; M D Randall; T M Griffith
Journal:  J Physiol       Date:  1999-10-15       Impact factor: 5.182

7.  The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons.

Authors:  A Szallasi; P M Blumberg; L L Annicelli; J E Krause; D N Cortright
Journal:  Mol Pharmacol       Date:  1999-09       Impact factor: 4.436

8.  Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

Authors:  C Ledent; O Valverde; G Cossu; F Petitet; J F Aubert; F Beslot; G A Böhme; A Imperato; T Pedrazzini; B P Roques; G Vassart; W Fratta; M Parmentier
Journal:  Science       Date:  1999-01-15       Impact factor: 47.728

9.  2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.

Authors:  T Sugiura; S Kondo; A Sukagawa; S Nakane; A Shinoda; K Itoh; A Yamashita; K Waku
Journal:  Biochem Biophys Res Commun       Date:  1995-10-04       Impact factor: 3.575

10.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

Authors:  R Mechoulam; S Ben-Shabat; L Hanus; M Ligumsky; N E Kaminski; A R Schatz; A Gopher; S Almog; B R Martin; D R Compton
Journal:  Biochem Pharmacol       Date:  1995-06-29       Impact factor: 5.858

View more
  71 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator.

Authors:  X Zhang; Y Maor; J F Wang; G Kunos; J E Groopman
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Angiogenesis: a new physiological role for N-arachidonoyl serine and GPR55?

Authors:  W-S V Ho
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 4.  N-acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets.

Authors:  Mark Connor; Chris W Vaughan; Robert J Vandenberg
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

5.  Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury.

Authors:  Aniv Mann; Reem Smoum; Victoria Trembovler; Alexander Alexandrovich; Aviva Breuer; Raphael Mechoulam; Esther Shohami
Journal:  J Neuroimmune Pharmacol       Date:  2015-02-27       Impact factor: 4.147

6.  Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass.

Authors:  Reem Smoum; Arik Bar; Bo Tan; Garry Milman; Malka Attar-Namdar; Orr Ofek; Jordyn M Stuart; Alon Bajayo; Joseph Tam; Vardit Kram; David O'Dell; Michael J Walker; Heather B Bradshaw; Itai Bab; Raphael Mechoulam
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

Review 7.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

Review 8.  Biosynthesis, degradation and pharmacological importance of the fatty acid amides.

Authors:  Emma K Farrell; David J Merkler
Journal:  Drug Discov Today       Date:  2008-04-03       Impact factor: 7.851

9.  Role of CB2 Receptor in the Recovery of Mice after Traumatic Brain Injury.

Authors:  Lital Magid; Sami Heymann; Merav Elgali; Liat Avram; Yoram Cohen; Sigal Liraz-Zaltsman; Raphael Mechoulam; Esther Shohami
Journal:  J Neurotrauma       Date:  2019-02-07       Impact factor: 5.269

Review 10.  Endocannabinoids and traumatic brain injury.

Authors:  R Mechoulam; E Shohami
Journal:  Mol Neurobiol       Date:  2007-09-18       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.